OncLive SOSS

The Talk

Lung Cancer TALK: A Review of Data from the IASLC 2020 World Conference on Lung Cancer
EP. 1: WCLC Updates in KRAS and Rare EGFR-Mutated NSCLC
EP. 2: WCLC Updates on the Emergence of ADCs in NSCLC
EP. 3: WCLC Updates in Immunotherapy for NSCLC
EP. 4: WCLC Updates in Neoadjuvant Therapy for NSCLC
EP. 5: WCLC Updates in Locally Advanced NSCLC
EP. 6: WCLC Updates in Small Cell Lung Cancer
“Multiple Myeloma Talk”: A Review of Data from the ASH 2020 Virtual Meeting
EP. 1: Updates in Multiple Myeloma in the Frontline Setting
EP. 2: Updates in Relapsed/Refractory Myeloma
EP. 3: Third and Subsequent Line Options for Multiple Myeloma
“Breast Cancer Talk” Review of Data from the SABCS 2020 Virtual Meeting
EP. 1: Metastatic Hormone-Receptor Positive Breast Cancer
EP. 2: Metastatic Hormone Epidermal Growth Factor Receptor 2-Positive Breast Cancer
EP. 3: Metastatic Triple-Negative Breast Cancer
“HER2 Breast Cancer Talk”: A Review of Data from the SABCS 2020 Virtual Symposium
EP. 1: Current Treatment Landscape for HER2+ Breast Cancer
EP. 2: Prognostic Tools for Early-Stage HER2+ Breast Cancer
EP. 3: Updated Data for Metastatic HER2+ Breast Cancer
Hematologic Malignancies Talk: Exciting Updates from ASH 2020 Virtual Meeting
EP. 1: ASH 2020 Updates in CLL
EP. 2: ASH 2020 Updates in Non-CLL B-Cell Lymphomas
EP. 3: ASH 2020 Updates in Relapsed/Refractory B-Cell Lymphomas
“Breast Cancer Talk”: Nursing Perspectives on HER2-Targeted Agents in Breast Cancer
EP. 1: Practical Management of Early Stage HER2+ Breast Cancer
EP. 2: HER2-targeted Therapy: Routes of Administration
EP. 3: FDA-approved Therapies for Relapsed/Refractory HER2+ mBC
EP. 4: Management of Adverse Effects in R/R HER2+ mBC
x